| 2026-04-17 | Dr. Frank T. WeberMD, CEO, Chief Medical Officer & Executive Director | 150,00k | 0,00 | Open Market Derivative Acquisition | - | - | - |
| 2026-04-17 | Dr. Julia NeugebauerHead of Investor Relations & Communications, COO & Executive Board Member | 150,00k | 0,00 | Open Market Derivative Acquisition | - | - | - |
| 2026-04-17 | Dr. Michael SchaefferChief Business Officer & Executive Director | 75,00k | 0,00 | Open Market Derivative Acquisition | - | - | - |
| 2025-12-10 | Dr. Frank T. WeberMD, CEO, Chief Medical Officer & Executive Director | 30,60k | 64,51k | Kauf | 2,11 | 230,15k | 15,33% |
| 2025-10-16 | Dr. Julia NeugebauerHead of Investor Relations & Communications, COO & Executive Board Member | 20,00k | 0,00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-30 | Dr. Erich M. PlatzerIndependent Non-Executive Chairman | 25,00k | 0,00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-30 | Ms. Charlotte LohmannIndependent Vice Chair of the Board | 25,00k | 0,00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-30 | Dr. Claudia RiedlIndependent Non-Executive Director | 25,00k | 0,00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-30 | Dr. Samir ShahIndependent Non-Executive Director | 25,00k | 0,00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-24 | Dr. Julia NeugebauerHead of Investor Relations & Communications, COO & Executive Board Member | 50,00k | 0,00 | Open Market Derivative Acquisition | - | - | - |